Wearable injectors are compact, portable self-injection devices specifically designed to enable subcutaneous delivery of substantial amounts of drugs, producing a sustained therapeutic effect. These innovative systems offer numerous dosing options (basal, bolus or continuous), improving patient adherence and efficacy of treatments.

The financial opportunity within the wearable injectors market has been analyzed across the following segments:

§  Type of Device

• Patch Pumps / Injectors
• Infusion Pumps / Injectors

§  Usability

• Disposable
•  Reusable

§  Therapeutic Area

• Autoimmune Disorders
• Cardiovascular Disorders
• Metabolic Disorders
• Neurological Disorders
• Oncological Disorders
• Other Disorders

§  Key Geographical Regions

• North America
• Europe
• Asia
• Latin America

§  Middle East and North Africa

The “Wearable Injectors Market 2023-2035” report features the following companies, which we identified to be key players in this domain:

§  CCBio

§  CeQur

§  Debiotech

§  Elcam Drug Delivery Devices

§  Eli Lilly

§  Enable Injections

§  Gerresheimer

§  Insulet

§  Medtronic

§  Medtrum Technologies

§  Pharmasense

§  Roche

§  Sonceboz

§  SOOIL Development

§  Weibel CDS

§  West Pharmaceuticals

Table of Contents

1.         PREFACE

2.         RESEARCH METHODOLOGY

3.          ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS    

4.         EXECUTIVE SUMMARY

5.         INTRODUCTION

6.         LARGE VOLUME WEARABLE INJECTORS FOR NON-INSULIN DRUGS: CURRENT MARKET LANDSCAPE

7.         LARGE VOLUME DRUG DEVICE COMBINATIONS FOR NON-INSULIN DRUGS: CURRENT MARKET LANDSCAPE

8.         LARGE VOLUME WEARABLE INJECTORS FOR INSULIN DRUGS: CURRENT MARKET LANDSCAPE

9.         PRODUCT COMPETITIVENESS ANALYSIS

10.       LARGE VOLUME WEARABLE INJECTOR DEVELOPERS: COMPANY PROFILES

11.       DRUG-DEVICE COMBINATIONS: DEVICE PROFILES

12.       PARTNERSHIPS AND COLLABORATIONS

13.       KEY ACQUISITION TARGETS

14.       PATENT ANALYSIS

15.       LARGE VOLUME WEARABLE INJECTORS: LIKELY DRUG CANDIDATES

16.       CLINICAL TRIAL ANALYSIS

17.       FUNDING AND INVESTMENT ANALYSIS

18.       CASE STUDY: ROLE OF CONTRACT MANUFACTURING ORGANIZATIONS IN DEVICE DEVELOPMENT SUPPLY CHAIN

19.       REGULATORY AND REIMBURSEMENT LANDSCAPE FOR MEDICAL DEVICES

20.       MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

21.       MARKET SIZING AND OPPORTUNITY ANALYSIS FOR LARGE VOLUME WEARABLE INJECTORS FOR NON-INSULIN DRUGS

22.       MARKET SIZING AND OPPORTUNITY ANALYSIS FOR LARGE VOLUME WEARABLE INJECTORS FOR INSULIN

23.       SWOT ANALYSIS

24.       CONCLUDING REMARKS

25.       EXECUTIVE INSIGHTS

26.       APPENDIX 1: TABULATED DATA

27.       APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/large-volume-wearable-injectors/238.html

Learn from experts:  do you know about these emerging industry trends?

Novel Spectrometry Platforms: Key Advancements

Quantum Computing in Drug Discovery: Unleashing the Power

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com